DaVita Responds to COVID Custom Case Solution & Analysis

Evidence Brief: DaVita Case Data

Financial Metrics

• PPE Unit Costs: Face masks increased from 0.10 to 5.00 per unit during the initial surge.
• Labor Costs: Implementation of crisis pay and relief funds for 65000 teammates.
• Scale: 200000 plus patients served across 2753 outpatient centers.
• Market Position: Approximately one third of the United States dialysis market share.

Operational Facts

• Clinic Operations: Centers remained open six days per week; dialysis is a non elective procedure.
• Patient Risk: High mortality rates for kidney patients contracting COVID 19 due to comorbidities.
• Supply Chain: Shift from just in time inventory to massive stockpiling of masks, gowns, and face shields.
• Cohorting: Creation of dedicated COVID 19 positive shifts and clinics to prevent cross contamination.

Stakeholder Positions

• Javier Rodriguez (CEO): Focused on clinical outcomes and long term transition to home based care.
• Kenny Gardner (Chief People Officer): Prioritized teammate safety and psychological well being to prevent burnout.
• Dr. Jeff Giullian (Chief Medical Officer): Advocated for data driven infection control and clinical protocols.
• Patients: Expressed fear of clinic environments while requiring life sustaining treatment three times weekly.

Information Gaps

• Specific Margin Impact: The exact basis point compression resulting from PPE price gouging is not explicitly stated.
• Competitor Response: Limited data on how smaller independent clinics managed supply chain disruptions compared to DaVita.
• Regulatory Duration: Uncertainty regarding how long CMS (Centers for Medicare and Medicaid Services) would maintain expanded telehealth reimbursements.

Strategic Analysis

Core Strategic Question

• How can DaVita maintain the integrity of its clinic based care model during a public health crisis while simultaneously accelerating the capital intensive transition to home dialysis?

Structural Analysis

The dialysis industry faced a sudden shift in the PESTEL framework, specifically in the Social and Technological categories. Patient vulnerability made the traditional centralized clinic model a liability. However, the regulatory environment eased, allowing for rapid telehealth adoption. Using a Value Chain lens, the primary bottleneck shifted from Operations to Inbound Logistics (PPE) and Human Resources (staff safety). The structural problem is the high fixed cost of physical clinics versus the rising variable cost of safe treatment delivery.

Strategic Options

1. Aggressive Home Dialysis Pivot: Reallocate capital from new clinic openings to home training programs and remote monitoring technology.
   • Rationale: Reduces patient exposure and aligns with long term industry trends.
   • Trade-offs: Requires significant patient education and home infrastructure; risks underutilizing existing clinic real estate.
   • Resource Requirements: Expansion of the home nursing workforce and investment in portable dialysis hardware.
2. Operational Fortress Model: Focus exclusively on making clinics the safest possible environment through advanced cohorting and ventilation upgrades.
   • Rationale: Protects the core revenue stream and ensures care for patients unable to perform home dialysis.
   • Trade-offs: High ongoing operational expense for PPE and specialized labor.
   • Resource Requirements: Centralized procurement task force and enhanced clinical safety protocols.

Preliminary Recommendation

Pursue the Aggressive Home Dialysis Pivot. The pandemic has functioned as a proof of concept for remote care. While the Fortress Model is necessary for immediate survival, the Home Pivot secures the future of the business. DaVita must utilize its scale to dominate the home care segment before smaller players or tech startups can establish a foothold. The economic benefit of lower overhead in the long term outweighs the immediate transition costs.

Implementation Roadmap

Critical Path

• Phase 1 (Days 1-30): Centralize PPE procurement to bypass traditional distributors and secure direct manufacturer contracts.
• Phase 2 (Days 31-60): Launch the Village Vital Signs dashboard to track teammate health and clinic capacity in real time.
• Phase 3 (Days 61-90): Initiate large scale retraining of clinic staff to serve as home dialysis coordinators.

Key Constraints

• Staff Attrition: The physical and emotional toll on frontline nurses may lead to a labor shortage that stalls home care training.
• Supply Chain Fragility: Continued volatility in the global market for medical grade plastics affects both clinic and home equipment.
• Patient Literacy: A significant portion of the patient population may lack the digital literacy or home stability required for self administered care.

Risk Adjusted Implementation Strategy

Implementation must account for the reality of clinician burnout. Instead of a mandatory shift to home care support, DaVita should offer incentivized training modules. To mitigate supply risks, the company must establish a three month safety stock of all critical components, moving away from lean inventory models permanently. Contingency plans include using existing clinics as micro distribution hubs for home supplies if national logistics networks fail.

Executive Review and BLUF

Bottom Line Up Front

DaVita must prioritize the transition to home dialysis as the primary vehicle for long term growth. The pandemic exposed the fragility of the clinic centric model. By accelerating the shift to home care, the company reduces patient risk, lowers long term real estate costs, and aligns with regulatory preferences for lower cost care settings. Immediate focus must remain on staff retention and supply chain sovereignty to ensure the core business remains stable during this transition. Speed of execution in the home segment is the critical differentiator.

Dangerous Assumption

The analysis assumes that the regulatory flexibilities granted during the pandemic, specifically regarding telehealth reimbursement and home care oversight, will become permanent. If CMS reverts to pre pandemic restrictions, the ROI on home care infrastructure will be significantly delayed.

Unaddressed Risks

• Competitor Consolidation: Smaller providers may merge to create a secondary scale player capable of challenging DaVita on PPE procurement. (Probability: Medium; Consequence: High)
• Technological Obsolescence: Rapid advancement in wearable artificial kidneys could render current home dialysis hardware obsolete within five years. (Probability: Low; Consequence: Extreme)

Unconsidered Alternative

The team did not fully evaluate a Joint Venture model with hospital systems to offload the highest risk COVID 19 patients. This would have reduced the operational burden on DaVita clinics and allowed the company to focus purely on non infected maintenance patients, potentially lowering PPE burn rates and staffing complexity.

Verdict

APPROVED FOR LEADERSHIP REVIEW